Increased aortic stiffness predicts future development and progression of peripheral neuropathy in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study

Diabetologia

Volumn 58, Issue 9, 2015, Pages 2161-2168

  Cardoso, Claudia R L ^a   Moran, Camila B M ^a   Marinho, Fernanda S ^a   Ferreira, Marcel T ^a   Salles, Gil F ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Aortic stiffness; Diabetic peripheral neuropathy; Glycaemic control; Predictors; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTERIAL STIFFNESS; ARTICLE; CAROTID FEMORAL PULSE WAVE VELOCITY; CLINICAL LABORATORY; COHORT ANALYSIS; DIABETIC NEUROPATHY; DISEASE COURSE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; AGED; AORTA; ARTERY; BLOOD; INSULIN DEPENDENT DIABETES MELLITUS; MICROCIRCULATION; MULTIVARIATE ANALYSIS; PATHOLOGY; PERIPHERAL NEUROPATHY; POISSON DISTRIBUTION; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AORTA; ARTERIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL NERVOUS SYSTEM DISEASES; POISSON DISTRIBUTION; PROGNOSIS; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84938746501     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3658-9     Document Type: Article

References (34)

1. Tesfaye S, Boulton AJ, Dyck PJ et al (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33:2285–2293
2. Cameron NE, Eaton SE, Cotter MA, Tesfaye S (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44:1973–1988
3. Giannini C, Dyck PJ (1994) Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus. Ann Neurol 36:408–415
4. Coppini DV, Bowtell PA, Weng C, Young PJ, Sönksen PH (2000) Showing neuropathy is related to increased mortality in diabetic patients—a survival analysis using an accelerated failure time model. J Clin Epidemiol 53:519–523
5. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J (2005) The global burden of diabetic foot disease. Lancet 366:1719–1724
6. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA (2003) The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 26:1790–1795
7. Albers JW, Herman WH, Pop-Busui R, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group et al (2010) Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care 33:1090–1096
8. Tesfaye S, Chaturvedi N, Eaton SE, EURODIAB Prospective Complications Study Group et al (2005) Vascular risk factors and diabetic neuropathy. N Engl J Med 352:341–350
9. Ismail-Beigi F, Craven T, Banerji MA, ACCORD trial group et al (2010) Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376:419–430
10. Charles M, Ejskjaer N, Witte DR, Borch-Johnsen K, Lauritzen T, Sandbaek A (2011) Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study. Diabetes Care 34:2244–2249
11. Pop-Busui R, Lu J, Brooks MM, BARI 2D Study Group et al (2013) Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort. Diabetes Care 36:3208–3215
12. Callaghan BC, Little AA, Feldman EL, Hughes RA (2012) Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev, Issue 6, CD007543. doi:10.1002/14651858.CD007543.pub2
13. Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH (2011) Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 57:1511–1522
14. Kimoto E, Shoji T, Shinohara K et al (2003) Preferential stiffening of central over peripheral arteries in type 2 diabetes. Diabetes 52:448–452
15. Cardoso CR, Ferreira MT, Leite NC, Barros PN, Conte PH, Salles GF (2009) Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients. Atherosclerosis 205:472–476
16. Kim ES, Moon SD, Kim HS et al (2011) Diabetic peripheral neuropathy is associated with increased arterial stiffness without changes in carotid intima-media thickness in type 2 diabetes. Diabetes Care 34:1403–1405
17. Laurent S, Cockcroft J, van Bortel L et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588–2605
18. Cardoso CR, Ferreira MT, Leite NC, Salles GF (2013) Prognostic impact of aortic stiffness in high-risk type 2 diabetic patients: the Rio de Janeiro Type 2 Diabetes Cohort Study. Diabetes Care 36:3772–3778
19. Cardoso CR, Leite NC, Ferreira MT, Salles GF (2015) Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study. Acta Diabetol 52:21–29
20. Salles GF, Leite NC, Pereira BB, Nascimento EM, Cardoso CR (2013) Prognostic impact of clinic and ambulatory blood pressure components in high-risk type 2 diabetic patients: the Rio de Janeiro Type 2 Diabetes Cohort Study. J Hypertens 31:2176–2186
21. Van Bortel LM, Laurent S, Boutouyrie P, Artery Society; European Society of Hypertension Working Group on Vascular Structure and Function; European Network for Noninvasive Investigation of Large Arteries et al (2012) Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 30:445–448
22. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH (1993) A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36:150–154
23. Symons MJ, Moore DT (2002) Hazard rate ratio and prospective epidemiological studies. J Clin Epidemiol 55:893–899
24. Yokoyama H, Yokota Y, Tada J, Kanno S (2007) Diabetic neuropathy is closely associated with arterial stiffening and thickness in type 2 diabetes. Diabet Med 24:1329–1335
25. Laurent S, Boutouyrie P (2007) Recent advances in arterial stiffness and wave reflection in human hypertension. Hypertension 49:1202–1206
26. Ferreira MT, Leite NC, Cardoso CR, Salles GF (2015) Correlates of aortic stiffness progression in patients with type 2 diabetes: importance of glycemic control. The Rio de Janeiro type 2 diabetes cohort study. Diabetes Care 38:897–904
27. Forrest KY, Maser RE, Pambianco G, Becker DJ, Orchard TJ (1997) Hypertension as a risk factor for diabetic neuropathy: a prospective study. Diabetes 46:665–670
28. Martin CL, Albers JW, Pop-Busui R, DCCT/EDIC Research Group (2014) Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care 37:31–38
29. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383–393
30. Duckworth W, Abraira C, Moritz T, Investigators VADT et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360:129–139
31. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M (1995) Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333:89–94
32. Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG (1997) Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 20:1162–1167
33. van de Poll-Franse LV, Valk GD, Renders CM, Heine RJ, van Eijk JT (2002) Longitudinal assessment of the development of diabetic polyneuropathy and associated risk factors. Diabet Med 19:771–776
34. Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR (2002) UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 25:894–899